Point-of-care testing of hemostatic alterations in anaesthesia and intensive care;Patientennahe sofortdiagnostik von hämostaseveränderungen in der anästhesie und intensivmedizin

Anaesthesist

Volumn 52, Issue 3, 2003, Pages 229-237

  Calatzis, A ^a   Heesen, M ^b   Spannagl, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Coagulation management; Haemostasis testing; Patient near analysis; Point of care testing

Indexed keywords

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; CRITICAL ILLNESS; HEMOSTASIS; HUMAN; INTENSIVE CARE; LABORATORY TEST; PATIENT MONITORING; QUALITY CONTROL; RISK BENEFIT ANALYSIS; VISCOELASTICITY;

ANESTHESIA; ANTICOAGULANTS; BLOOD COAGULATION TESTS; FIBRINOLYSIS; HEMOSTASIS; HEPARIN; HUMANS; INTENSIVE CARE; PARTIAL THROMBOPLASTIN TIME; PLATELET FUNCTION TESTS; POINT-OF-CARE SYSTEMS; QUALITY ASSURANCE, HEALTH CARE;

EID: 0344837840     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-002-0449-8     Document Type: Article

References (68)

1. Bara L, Planes A, Samama MM (1999) Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery. Br J Haematol 104:230-240
2. Beholz S, Grubitzsch H, Bergmann B, Wollert HG, Eckel L (1999) Hemostasis management by use of Hepcon/HMS: increased bleeding without increased need for blood transfusion. Thorac Cardiovasc Surg 47:322-327
3. Besselaar AM van den (1985) Standardization of the prothrombin time in oral anticoagulant control. Haemostasis 15:271-277
4. Boldt J, Walz G, Triem J, Suttner S, Kumle B (1998) Point-of-care (POC) measurement of coagulation after cardiac surgery. Intensive Care Med 24:1187-1193
5. Boldt J, Huttner I, Suttner S, Kumle B, Piper SN, Berchthold G (2001) Changes of haemostasis in patients undergoing major abdominal surgery - is there a difference between elderly and younger patients? Br J Anaesth 87:435-440
6. Briedigkelt L, Muller-Plathe O, Schlebusch H, Ziems J (1999) Recommendations of the German Working Group on medical laboratory testing (AML) on the introduction and quality assurance of procedures for point-of-care testing (POCT) in hospitals. Clin Chem Lab Med 37:919-925
7. Brill-Edwards P, Ginsberg JS, Johnston M, Hirsh J (1993) Establishing a therapeutic range for heparin therapy. Ann Intern Med 119:104-109
8. Bundesärztekammer (2001) Richtlinien der Bundesärztekammer zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen. Dtsch Arztebl 42:2747-2759
9. Calatzis A, Haas S, Goedje O, Calatzis AI, Hipp R, Walenga JM (2000) Thrombelastographic coagulation monitoring during cardiovascular surgery with the ROTEG coagulation analyzer. In: Pifarée R (ed) Management of bleeding in cardiovascular surgery. Hanley & Belfus, Philadelphia, pp 215-226
10. Chandler WL (1995) Thethromboelastography and the thromboelastograph technique. Semin Thromb Hemost 21 [Suppl 4]:1-6
11. Chitolie A, Mackie IJ, Grant D, Hamilton JL, Machin SM (1994) Inaccuracy of the 'derived' fibrinogen measurement. Blood Coagul Fibrinolysis 5:955-957
12. Coiffic A, Cazes E, Janvier G, Forestier F, Lanza F, Nurden A, Nurden P (1999) Inhibition of platelet aggregation by abciximab but not by aspirin can be detected by a new point-of-care test, the hemostatus. Thromb Res 95:83-91
13. Cromheecke ME, Levi M, Colly LP, Mol BJ de et al. (2000) Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 356:97-102
14. Davis CL, Chandler WL (1995) Thromboelastography for the prediction of bleeding after transplant renal biopsy. J Am Soc Nephrol 6:1250-1255
15. Despotis GJ, Goodnough LT (2000) Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery. Ann Thorac Surg 70 [Suppl 2]:S20-32
16. Despotis GJ, Levine V, Filos KS, Santoro SA, Joist JH, Spitznagel E, Goodnough LT (1996) Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Anesthesiology 85:1311-1323
17. Eby C (1997) Standardization of APTT reagents for heparin therapy monitoring: urgent or fading priority? Clin Chem 43:1105-1107
18. Ereth MH, Nuttall GA, Klindworth JT et al. (1997) Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass? Anesth-Analg 85:259-264
19. Favaloro EJ (2002) Clinical application of the PFA-100. Curr Opin Hematol 9:407-415
20. Ferring M, Reber G, Moerloose P de, Merlani P, Diby M, Ricou B (2001) Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients. Can J Anaesth 48:1155-1160
21. Fressinaud E, Veyradier A, Truchaud F, Martin I, Boyer-Neumann C, Trossaert M, Meyer D (1998) Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 15:1325-1331
22. Gelb AB, Roth RI, Levin J et al. (1996) Changes in blood coagulation during and following cardiopulmonary bypass: lack of correlation with clinical bleeding. Am J Clin Pathol 106:87-99
23. Gravlee GP, Arora S, Lavender SW et al. (1994) Predictive value of blood clotting tests in cardiac surgical patients. Ann Thorac Surg 58:216-221
24. Hafner G, Roser M, Nauck M (2002) Methods for the monitoring of direct thrombin inhibitors. Semin Thromb Hemost 28:425-430
25. Harder S, Klinkhardt U, Graff J et al. (2001) In vitro dose response to different GPIIb/IIIa-antagonists: inter-laboratory comparison of various platelet function tests. Thromb Res 102:39-48
26. Hartert H (1948) Blutgerinnungstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr 26:577-583
27. Hattersley PG (1966) Activated coagulation time of whole blood. JAMA 196:436-440
28. Heesen M, Kemkes-Matthes B, Deinsberger W, Boldt J, Matthes KJ (1999) Coagulation alterations in patients undergoing elective craniotomy. Surg Neurol 47:35-38
29. Henry TD, Satran D, Knox LL, Iacarella CL, Laxson DD, Antman EM (2001) Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin? Am Heart J 142:590-593
30. Hett DA, Walker D, Pilkington SN, Smith DC (1995) Sonoclot analysis. Br J Anaesth 75:771-776
31. Hicks JM, Haeckel R, Price CP, Lewandrowski K, Wu AH (1999) Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium. Clin Chim Acta 303:1-17
32. Hoffmann JJ, Meulendijk PN (1978) Comparison of reagents for determining the activated partial thromboplastin time. Thromb Haemost 30:640-645
33. Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W (2000) Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost 83:316-321
34. Hubbard AR, Rigsby P, Barrowcliffe TW (2001) Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586). Thromb Haemost 85:634-638
35. Huttner I, Boldt J, Haisch G, Suttner S, Kumle B, Schulz H (2000) Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery. Br J Anaesth 85:417-423
36. Innerhofer P, Fries D, Margreiter J et al. (2002) The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 95:858-865
37. Isgro F, Rehn E, Kiessling AH, Kretz KU, Kilian W, Saggau W (2002) Platelet function test Hemo-STATUS 2: tool or toy for an optimized management of hemostasis? Perfusion 17:27-31
38. Jennings I, Luddington RJ, Baglin T (1991) Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation. J Clin Pathol 44:950-953
39. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL (1997) Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 42:716-720
40. Kemme MJ, Faaij RA, Schoemaker RC, Kluft C, Meijer P, Cohen AF, Burggraaf J (2001) Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulants. Blood Coagul Fibrinolysis 12:583-591
41. Koster A, Kukucka M, Fischer T, Hetzer R, Kuppe H (2001) Evaluation of post-cardiopulmonary bypass coagulation disorders by differential diagnosis with a multichannel modified thromboelastogram: a pilot investigation. J Extra Corpor Technol 33:153-158
42. Koster A, Fischer T, Praus M, Haberzettl H, Kuebler WM, Hetzer R, Kuppe H (2002) Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology 97:837-841
43. Koster A, Sanger S, Knorig FJ, Kuppe H, Hetzer R, Loebe M (2002) Autologous plasma and platelet sequestration at the beginning of cardiopulmonary bypass: a pilot investigation in five patients undergoing extended vascular surgery in deep hypothermia. ASAIO J 48:106-109
44. Lasne D, Fiemeyer A, Chatellier G, Chammas C, Baron JF, Aiach M (2000) A study of platelet functions with a new analyzer using high shear stress (PFA 100) in patients undergoing coronary artery bypass graft. Thromb Haemost 84:794-799
45. Leyvi G, Shore-Lesserson L, Harrington D, Vela-Cantos F, Hossain S (2001) An investigation of a new activated clotting time "MAXACT" in patients undergoing extracorporeal circulation. Anesth Analg 92:578-583
46. Lippi G, Veraldi GF, Fraccaroli M, Manzato F, Cordiano C, Guidi G (2001) Variation of plasma D-dimer following surgery: implications for prediction of postoperative venous thromboembolism. Clin Exp Med 1:161-164
47. Maat MP de, Meijer P, Nieuwenhuizen W, Haverkate F, Kluft C (2000) Performance of semiquantitative and quantitative D-dimer assays in the ECAT external quality assessment program. Semin Thromb Hemost 26:625-630
48. Mammen EF, Comp PC, Gosselin R et al. (1998) PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 24:195-202
49. Meijer P, Verbruggen HW, Weerd B de, Dool EJ den, Oerle R van (2002) Effect of a common reference plasma on the inter-laboratory variation of the measurement of total and free protein S: a collaborative study of the Dutch Working Group on Haemostasis Laboratory Diagnosis. Scand J Clin Lab Invest 62:149-157
50. Munro J, Booth A, Nicholl J (1997) Routine preoperative testing: a systematic review of the evidence. Health Technol Assess 1:pi-iv;1-62
51. Murray DJ, Brosnahan WJ, Pennell B, Kapalanski D, Weiler JM, Olson J (1997) Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays. J Cardiothorac Vasc Anesth 11:24-28
52. Neumann FJ, Hochholzer W, Pogatsa-Murray G, Schomig A, Gawaz M (2001) Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting. J Am Coll Cardiol 37:1323-1328
53. Nowak G, Bucha E (1996) Quantitative determination of hirudin in blood and body fluids. Semin Thromb Hemost 22:197-202
54. Oral Anticoagulation Monitoring Study Group (2001) Point-of-care prothrombin time measurement for professional and patient self-testing use. A multicenter clinical experience. Am J Clin Pathol 115:288-296
55. Oren A, Breumelhof R, Timmer R, Biesma DH, Hoekstra JB (1999) Abnormal clotting parameters before therapeutic ERCP: do they predict major bleeding? Eur J Gastroenterol Hepatol 11:1093-1097
56. Orlikowski CE, Payne AJ, Moodley J, Rocke DA (1992) Thrombelastography after aspirin ingestion in pregnant and non-pregnant subjects. Br J Anaesth 69:159-161
57. Riley RS, Rowe D, Fisher LM (2000) Clinical utilization of the international normalized ratio (INR). J Clin Lab Anal 14:101-114
58. Salooja N, Perry DJ (2001) Thrombelastography. Blood Coagul Fibrinolysis 12:327-337
59. Seay RE, Uden DL, Kriesmer PJ, Payne NR (1993) Predictive performance of three methods of activated clotting time measurement in neonatal ECMO patients. ASAI J 39:39-42
60. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA (1999) Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 88:312-319
61. Simon DI, Liu CB, Ganz P et al. (2001) A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Catheter Cardiovasc Interv 52:425-432
62. Smith JW, Steinhubl SR, Lincoff AM, Coleman JC, Lee TT, Hillman RS, Coller BS (1999) Rapid platelet-function assay: an automated and quantitative cartridge-based method. Circulation 99:620-625
63. Spiess BD, Gillies BS, Chandler W, Verrier E (1995) Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 9:168-173
64. Steinhubl SR, Talley JD, Braden GA et al. (2001) Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation 103:2572-2578
65. Tripodi A, Chantarangkul V, Mannucci P (2001) Near-patient testing devices to monitor oral anticoagulant therapy. Br J Haematol 113:847-852
66. Vorweg M, Hartmann B, Knuttgen D, Jahn MC, Doehn M (2001) Management of fulminant fibrinolysis during abdominal aortic surgery. J Cardiothorac Vasc Anesth 15:764-767
67. Wahba A, Sander S, Birnbaum DE (1998) Are invitro platelet function tests useful in predicting blood loss following open heart surgery? Thorac Cardiovasc Surg 46:228-231
68. Yuoh C, Tarek Elghetany M, Petersen JR, Mohammad A, Okorodudu AO (2001) Accuracy and precision of point-of-care testing for glucose and prothrombin time at the critical care units. Clin Chim Acta 307:119-123